Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

The latent reservoir: why HIV still has no cure

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Antiretroviral treatment works so well that the virus becomes undetectable in blood. Stop the treatment, and within weeks it is back. For forty years that has been the central puzzle of HIV.

The answer is a small, stubborn population of cells, established within days of infection, that nothing available can reach.

Related pages: HIV

The bottom line

What we know
  • HIV inserts its DNA into host chromosomes, and some of those cells then go quiet.
  • Resting cells making no viral protein are invisible to both the immune system and to antiretroviral drugs.
  • The reservoir is established within the first days to weeks of infection, before most people know they are infected.
  • Stopping treatment leads to viral rebound in nearly everyone, usually within weeks.
What is still open
  • How large the reservoir really is, since most integrated viral DNA is defective and cannot make working virus.
  • Whether any approach short of a stem cell transplant can clear or permanently silence it.

The story, step by step

  1. 1. How it forms ()
  2. 2. How early ()
  3. 3. Why rebound happens ()
  4. 4. The cured ()
  5. 5. What's being tried ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

A cell goes quiet with the virus inside it

Lab or animal study

What happens

Memory T-cells are built to last. That is normally a good thing.

What the research shows

  • When an infected CD4 cell returns to a resting memory state, the integrated viral DNA goes silent with it.
  • The cell makes no viral protein, so no immune cell can tell it apart from any other memory cell.
  • Antiretroviral drugs block new infection; they do nothing to a cell that is not currently making virus.
  • These cells persist for years and divide, copying the viral DNA along with their own.

Why it matters

The reservoir is not a hiding place the virus finds. It is a consequence of how long-lived immune memory works.

What's still uncertain

  • Other cell types, including some macrophages and cells in the brain and gut, may also hold virus, and how much they contribute is debated.

Read more

Next: How early

Part 2 of 5

Within days, before anyone knows

Lab or animal study

What happens

The timing is what makes this so hard to prevent.

What the research shows

  • Studies of people treated extremely early still find a reservoir, though a smaller one.
  • Even treatment started during the first weeks of infection does not prevent it entirely.
  • The size of the reservoir at the time treatment begins predicts how quickly virus returns if treatment is stopped.
  • Most of the viral DNA that can be found is defective and cannot make working virus, which makes measuring the real reservoir genuinely difficult.

Why it matters

Early diagnosis and immediate treatment still matter enormously, but not because they avoid the reservoir. They limit it.

What's still uncertain

  • There is no routine clinical test that measures a person's reservoir. The assays used are research tools.

Read more

Next: Why rebound happens

Part 3 of 5

Stopping treatment is not a neutral experiment

Lab or animal study

What happens

Treatment interruption has been studied directly, and the results are consistent.

What the research shows

  • In nearly everyone, virus returns in blood within two to four weeks of stopping.
  • Rebound usually comes from the reservoir, not from new infection.
  • A rebound can be accompanied by a sharp drop in CD4 count and by a period of high infectiousness.
  • A very small number of people, sometimes called post-treatment controllers, keep the virus down for months or years after stopping, and researchers are studying why.

Why it matters

This is the practical reason treatment is lifelong, and the reason stopping medication because you feel well is one of the few genuinely dangerous things a person with HIV can do.

What's still uncertain

  • Why post-treatment controllers exist, and whether that state can be induced on purpose, is unresolved.

Read more

Next: The cured

Part 4 of 5

About a dozen people, all through cancer treatment

Review of many studies

What happens

A small number of people are considered cured of HIV. Every one of them had a life-threatening blood cancer.

What the research shows

  • Each received a stem cell transplant, in most cases from a donor with two copies of the CCR5-delta32 mutation, which removes the doorway HIV uses to enter cells.
  • The first was Timothy Ray Brown, the Berlin patient, in 2008. By 2026 roughly a dozen such cases had been reported, including patients described as the Oslo, Toronto, Kansas City and Essen patients.
  • The transplant itself carries a high risk of death and is only justified by the cancer, not by HIV.
  • At least one case involved a donor with only one copy of the mutation, which suggests the transplanted immune system itself does part of the work.

Why it matters

These cases prove a cure is biologically possible. They are not a treatment anyone can be offered for HIV alone.

What's still uncertain

  • Why the transplant works in these people and not in every similar case is still being studied, including the role of graft-versus-host disease.

Read more

Next: What's being tried

Part 5 of 5

Shock and kill, block and lock, and gene editing

Lab or animal study

What happens

Research is pointed at the reservoir from several directions at once.

What the research shows

  • Shock and kill: wake the silent cells with latency-reversing agents so the immune system or drugs can destroy them. Trials have woken cells but have not meaningfully shrunk the reservoir.
  • Block and lock: do the opposite, and seal the viral DNA permanently shut so it can never restart.
  • Broadly neutralizing antibodies, given alone or with other agents, to control virus without daily pills.
  • Gene editing of a person's own cells to remove CCR5, or to cut the viral DNA out, is in early trials.
  • Therapeutic vaccines aimed at training the immune system to hold the virus down without medication.

Why it matters

None of these is close to clinical use, and anything sold as an HIV cure today is a fraud. Treatment is what works now, and it works very well.

What's still uncertain

  • Most cure trials so far measure laboratory markers rather than time off treatment, which is the outcome that would actually matter.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.